Price $5.57 |
Market Cap
203.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.96
|
P/S
3.13
|
Dividend %
-
|
|
P/CF
8.1
|
P/FCF
-
|
Op. Cash Flow
-63.6K
|
FCF
-1.9
|
|
Op. Margin
-48.00%
|
Net Margin
-42.00%
|
ROE
-25.70%
|
ROI
-30.10%
|
|
ROA
-11.20%
|
EPS Growth
-56.10%
|
Current Ratio
2.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $140.31 | - | 2.00% | 48.86B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.61 | - | - | 97.7M | Strong Buy |
| Champions Oncology Inc (CSBR) | $7.90 | - | - | 114.3M | Strong Buy |
| Infinity Pharmaceuticals Inc. (INFI) | $1.57 | - | - | 107M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.15 | - | - | 297M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
